Cited by 2,852Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

Cappato, Riccardo, Calkins, Hugh, Chen, Shih-Ann, Davies, Wyn, Iesaka, Yoshito, Kalman, Jonathan, Kim, You-Ho, Klein, George, Natale, Andrea, Packer, Douglas, Skanes, Allan, Ambrogi, Federico, Biganzoli, Elia·2010·Circulation Arrhythmia and Electrophysiology

DOI 10.1161/circep.109.859116

Open this paper in CoChat — free account

Abstract

BACKGROUND: The purpose of this study was to provide an updated worldwide report on the methods, efficacy, and safety of catheter ablation of atrial fibrillation (AF). METHODS AND RESULTS: A questionnaire with 46 questions was sent to 521 centers from 24 countries in 4 continents. Complete interviews were collected from 182 centers, of which 85 reported to have performed 20,825 catheter ablation procedures on 16,309 patients with AF between 2003 and 2006. The median number of procedures per center was 245 (range, 2 to 2715). All centers included paroxysmal AF, 85.9% also included persistent and 47.1% also included long-lasting AF. Carto-guided left atrial circumferential ablation (48.2% of patients) and Lasso-guided ostial electric disconnection (27.4%) were the most commonly used techniques. Efficacy data were analyzed with centers representing the unit of analysis. Of 16,309 patients with full disclosure of outcome data, 10 488 (median, 70.0%; interquartile range, 57.7% to 75.4%) became asymptomatic without antiarrhythmic drugs and another 2047 (10.0%; 0.5% to 17.1%) became asymptomatic in the presence of previously ineffective antiarrhythmic drugs over 18 (range, 3 to 24) months of follow-up. Success rates free of antiarrhythmic drugs and overall success rates were significantly larger in 9590 patients with paroxysmal AF (74.9% and 83.2%) than in 2800 patients with persistent AF (64.8% and 75.0%) and 1108 patients with long-lasting AF (63.1% and 72.3%) (P<0.0001). Major complications were reported in 741 patients (4.5%). CONCLUSIONS: When analyzed in a large number of electrophysiology laboratories worldwide, catheter ablation of AF shows to be effective in approximately 80% of patients after 1.3 procedures per patient, with approximately 70% of them not requiring further antiarrhythmic drugs during intermediate follow-up.

Integrity signals

Registry

Crossref · 10.1161/circep.109.859116

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Mouroux, A. L., Métayer, P. L., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 8,040
A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate
Nademanee, K., McKenzie, J. P., Kosar, E. M., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., Khunnawat, C., & Ngarmukos, T. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.054 · Cited by 2,004
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins
Chen, S., HSIEH, M., TAI, C., Tsai, C.-F., Prakash, V. S., Yu, W., Hsu, T., Ding, Y.-A., & Chang, M.-S. (1999) · Circulation · doi:10.1161/01.cir.100.18.1879 · Cited by 1,442
Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
Cappato, R., Calkins, H. G., Chen, S., Davies, W. D., Iesaka, Y., Kalman, J. M., Kim, Y.-H., Klein, G. J., Packer, D. L., & Skanes, A. C. (2005) · Circulation · doi:10.1161/01.cir.0000157153.30978.67 · Cited by 1,303
A Focal Source of Atrial Fibrillation Treated by Discrete Radiofrequency Ablation
Jaı̈s, P., Haı̈ssaguerre, M., Shah, D. C., Chouairi, S., Gencel, L., Hocini, M., & Clémenty, J. (1997) · Circulation · doi:10.1161/01.cir.95.3.572 · Cited by 1,114
Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation
Oral, H., Knight, B. P., Tada, H., Özaydın, M., Chugh, A., Hassan, S. A., Scharf, C., Lai, S. W. K., Greenstein, R., Pelosi, F., et al. (2002) · Circulation · doi:10.1161/hc0902.104712 · Cited by 1,112
Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
Oral, H., Pappone, C., Chugh, A., Good, E. D., Bogun, F. M., Pelosi, F., Bates, E., Lehmann, M. H., Vicedomini, G., Augello, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050955 · Cited by 975
Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci
Haı̈ssaguerre, M., Jaı̈s, P., Shah, D. C., Garrigue, S., Takahashi, A., Lavergne, T., Hocini, M., Peng, J. T., Roudaut, R. P., & Clémenty, J. (2000) · Circulation · doi:10.1161/01.cir.101.12.1409 · Cited by 921
Catheter Ablation for Paroxysmal Atrial Fibrillation
Oral, H., Scharf, C., Chugh, A., HALL, B. W., Cheung, P. W., Good, E. D., Veerareddy, S., Pelosi, F., & Morady, F. (2003) · Circulation · doi:10.1161/01.cir.0000095796.45180.88 · Cited by 896

Show all 34 references

Research works printed but not linked: 8

10.1161/circ.95.3.572 · DOI
10.1161/circ.100.11.1203 · DOI
10.1161/circ.105.9.1077 · DOI
10.1161/circ.100.20.2085 · DOI
10.1161/circ.101.12.1409 · DOI
10.1161/circ.99.2.262 · DOI
10.1161/circ.91.8.2264 · DOI
10.1161/circ.98.9.835 · DOI

Sorted by citations

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
“– 726,1039 In patients who experience symptomatic recurrences of AF despite antiarrhythmic drug therapy, all RCTs showed better sinus rhythm maintenance with catheter ablation than on antiarrhythmic drugs.(586,713,727,728) There is no current indication for catheter ablation to prevent cardiovascular outcomes (or desi…”
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,929
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,794
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,764
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Calkins, H. G., Kück, K., Cappato, R., Brugada, J., Camm, A. J., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Dimarco, J., et al. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9672-7 · Cited by 1,685
“In a more recent worldwide surveymonitoring the outcome and safety features of AF ablation performed between the years 2003 to 2006 [506], 85 participating centers proved to perform more efficiently than in the previous years.”
BackgroundResultInfluential
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation
Packer, D. L., Mark, D. B., Robb, R. A., Monahan, K. H., Bahnson, T. D., Poole, J. E., Noseworthy, P. A., Rosenberg, Y., Jeffries, N. O., Mitchell, L. B., et al. (2019) · JAMA · doi:10.1001/jama.2019.0693 · Cited by 1,538
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.12.016 · Cited by 1,456
Self-citation
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,338
Pathophysiological mechanisms of atrial fibrillation: a translational appraisal
Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux274 · Cited by 1,203
“It is difficult to directly compare adverse events from AF ablation to those from AADs.”
BackgroundMethodResultInfluential
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial
Wazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., et al. (2005) · JAMA · doi:10.1001/jama.293.21.2634 · Cited by 1,121
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129
Inflammation and the pathogenesis of atrial fibrillation
Hu, Y., Chen, Y., Lin, Y., & Chen, S. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.2 · Cited by 1,122
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 928
Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation
Packer, D. L., Kowal, R. C., Wheelan, K. R., Irwin, J. M., Champagne, J., Guerra, P. G., Dubuc, M., Reddy, V. Y., Nelson, L., Holcomb, R. G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.064 · Cited by 919
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
Jaı̈s, P., CAUCHEMEZ, B., Macle, L., Daoud, E. G., Khairy, P., Subbiah, R. N., Hocini, M., Extramiana, F., Sacher, F., Bordachar, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.772582 · Cited by 889
“... 51.111.1 Episodes per month, median (IQR), n 13.5 (4.0–30.0) 12.0 (3.0–30.0) 12.0 (4.0–30.0) Duration of episodes, median (IQR), h 4.0 (1.0–12.0) 6.0 (2.0–15.0) 5.5 (1.0–12.0) Patients with 1 DC shock, n (%) 9 (17.0) 12 (20.3) 21 (18.8) Embolic events, n (%) 1 (1.9) 7 (11.9) 8 (7.1) Diabetes mellitus, n (%) 1 (1.9…”
Influential
Safety of Percutaneous Left Atrial Appendage Closure
Reddy, V. Y., Holmes, D. R., Doshi, S. K., Neužil, P., & Kar, S. (2011) · Circulation · doi:10.1161/circulationaha.110.976449 · Cited by 863
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
Feltes, T. F., BACHA, E. A., Beekman, R. H., Cheatham, J. P., Feinstein, J. A., Gomes, A. S., Hijazi, Z. M., Ing, F. F., de Moor, M., Morrow, W. R., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31821b1f10 · Cited by 861
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses
Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.824789 · Cited by 847
Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis
Ganesan, A. N., Shipp, N. J., Brooks, A. G., Kuklik, P., Lau, D. H., Lim, H. S., Sullivan, T., Roberts‐Thomson, K. C., & Sanders, P. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.004549 · Cited by 800
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0678 · Cited by 758
Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation
Reddy, V. Y., Neužil, P., Koruth, J. S., Petrů, J., Funosako, M., Cochet, H., Šedivá, L., Chovanec, M., Dukkipati, S. R., & Jaı̈s, P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.021 · Cited by 716
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.08.001 · Cited by 709
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial
Morillo, C. A., Verma, A., Connolly, S. J., Kuck, K. H., Nair, G. M., Champagne, J., Sterns, L. D., Beresh, H., Healey, J. S., Natale, A., et al. (2014) · JAMA · doi:10.1001/jama.2014.467 · Cited by 667
Self-citation
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · EP Europace · doi:10.1093/europace/eul097 · Cited by 670
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary
Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 646
Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial
Verma, A., Haines, D. E., Boersma, L. V. A., Sood, N. A., Natale, A., Marchlinski, F. E., Calkins, H. G., Sanders, P., Packer, D. L., Kück, K., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.063988 · Cited by 629
“Amiodarone use during blanking period without previous use 0 (0) 4 (3)”
BackgroundMethodInfluential
Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation
Cappato, R., Calkins, H. G., Chen, S., Davies, W. D., Iesaka, Y., Kalman, J. M., Kim, Y.-H., Klein, G. J., Natale, A., Packer, D. L., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.022 · Cited by 583
In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010
Deshmukh, A. J., Patel, N., Pant, S., Shah, N. N., Chothani, A., Mehta, K. D., Grover, P. M., Singh, V., Vallurupalli, S., Savani, G. T., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003862 · Cited by 580
“2104 The past decade has seen catheter ablation of atrial fibril-lation (AF) transition from a new unproven procedure to a commonly performed procedure in most major medical centers throughout the world.1 Catheter ablation of AF has also evolved into a mainstay of therapy for patients with drugrefractory symptomatic A…”
BackgroundResultInfluential
Pulsed Field Ablation of Paroxysmal Atrial Fibrillation
Reddy, V. Y., Dukkipati, S. R., Neužil, P., Anić, A., Petrů, J., Funasako, M., Cochet, H., Minami, K., Brešković, T., Sikiric, I., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.02.014 · Cited by 569
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux275 · Cited by 521
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)†
Stabile, G., Bertaglia, E., Senatore, G., Simone, A. D., Zoppo, F., Donnici, G., Turco, P., Pascotto, P., FAZZARI, M., & Vitale, D. F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi583 · Cited by 502
Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
Biase, L. D., Burkhardt, J. D., Santangeli, P., Mohanty, P. K., Sánchez, J., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006426 · Cited by 485
The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study
Reddy, V. Y., Shah, D. C., Kautzner, J., Schmidt, B., Saoudi, N. C., Herrera‐Siklody, C., Jaı̈s, P., Hindricks, G., Peichl, P., Yulzari, A., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.07.016 · Cited by 486
Circumferential Pulmonary Vein Isolation With the Cryoballoon Technique
Neumann, T., Vogt, J., Schumacher, B., Dorszewski, A., Kuniss, M., Neuser, H., Kurzidim, K. W., Berkowitsch, A., Koller, M. L., Heintze, J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.021 · Cited by 474
Paroxysmal AF Catheter Ablation With a Contact Force Sensing Catheter
Natale, A., Reddy, V. Y., Monir, G., Wilber, D. J., Lindsay, B. D., McElderry, H. T., Kantipudi, C., MANSOUR, M. C., Melby, D. P., Packer, D. L., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.072 · Cited by 476
“48%) fell within the typical range published in the literature (1,17,18).”
Background
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013)
JCS Joint Working Group (2014) · Circulation Journal · doi:10.1253/circj.cj-66-0092 · Cited by 430
Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation
Berruezo, A., Tamborero, D., Mont, L., Benito, B., Tolosana, J. M., Sitges, M., Vidal, B., Arriagada, G., Mendez, F., Matiello, M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm027 · Cited by 407
Venice Chart International Consensus Document on Atrial Fibrillation Ablation
Natale, A., Raviele, A., Arentz, T., Calkins, H. G., Chen, S., Haı̈ssaguerre, M., Hindricks, G., Ho, S. Y., Kück, K., Marchlinski, F. E., et al. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00816.x · Cited by 404
Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST): A 2-Center Randomized Clinical Trial
Boersma, L. V. A., Castella, M., van Boven, W., Berruezo, A., Yilmaz, A., Nadal, M., Sandoval, E., Calvo, N., Brugada, J., Kelder, J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.074047 · Cited by 396
Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Oral, H., Chugh, A., Özaydın, M., Good, E. D., Fortino, J., Sankaran, S., Reich, S., Igic, P., Elmouchi, D., Tschopp, D. R., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.641225 · Cited by 397
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)
Mont, L., Bisbal, F., Hernández-Madrid, A., Pérez-Castellano, N., Viñolas, X., Arenal, A., Arribas, F., Fernández-Lozano, I., Bodegas, A., Cobos, A., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht457 · Cited by 394
“Furthermore, CA had an acceptable safety profile according to the latest international registries.(17)”
MethodResult
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
Wann, L. S., Curtis, A. B., Ellenbogen, K. A., Estes, N. A. M., Ezekowitz, M. D., Jackman, W. M., January, C. T., Lowe, J. E., Page, R. L., Slotwiner, D. J., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.01.032 · Cited by 394
Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force–Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation
Reddy, V. Y., Dukkipati, S. R., Neužil, P., Natale, A., Albenque, J.-P., Kautzner, J., Shah, D. C., Michaud, G. F., Wharton, M., Harari, D., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014092 · Cited by 383
“3%.(3,19,20) The recently published SMART-AF trial with another CF-sensing ablation catheter reported a higher cardiac tamponade rate of 2.”
Radiofrequency Catheter Ablation of Atrial Fibrillation: A Cause of Silent Thromboembolism?
Gaïta, F., Caponi, D., Pianelli, M., Scaglione, M., Toso, E., Cesarani, F., Boffano, C., Gandini, G., Valentini, M. C., Ponti, R. D., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.937953 · Cited by 363
Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies
Andrade, J. G., Khairy, P., Guerra, P. G., Deyell, M. W., Rivard, L., Macle, L., Thibault, B., Talajic, M. R., Roy, D., & Dubuc, M. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.03.050 · Cited by 360
Incidence of Asymptomatic Intracranial Embolic Events After Pulmonary Vein Isolation
Herrera‐Siklody, C., Deneke, T., Hocini, M., Lehrmann, H., Shin, D., Miyazaki, S., Henschke, S., Flügel, P.-C., SCHIEBELING‐RÖMER, J., Bansmann, P. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.010 · Cited by 357
“conventional RF ablation (5), recent evidence suggests a higher rate of subclinical cerebral emboli detected by imaging (6).”
Background
Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
Lakkireddy, D., Reddy, Y. M., Biase, L. D., Vanga, S. R., Santangeli, P., Swarup, V., Pimentel, R., MANSOUR, M. C., d’Ávila, A., Sánchez, J., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.014 · Cited by 356
The 'single big cryoballoon' technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study
Chun, K. R. J., Schmidt, B., Metzner, A., Tilz, R. R., Zerm, T., Köster, I., Fürnkranz, A., Koektuerk, B., Konstantinidou, M., Antz, M., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn570 · Cited by 350
“... RIPV: hockey stick 18 28 2 2 1 1 100 19 28 4 1 9 100 LCPV: crosstalk; RIPV: pull-down; LIPV: pull-down 20 28 4 1 5 100 LCPV: crosstalk; RIPV: pull-down; LIPV: pull-down 21 28 2 3 1 8 100 RIPV: pull-down 22 28 2 2 3 3 100 RIPV: pull-down 23 28 3 2 1 3 100 RIPV: pull-down 24 28 2 2 1 3 100 RIPV: pull-down 25 28 2 3…”
Phrenic Nerve Injury After Atrial Fibrillation Catheter Ablation
Sacher, F., Monahan, K. H., Thomas, S. P., Davidson, N. C., Adragão, P., Sanders, P., Hocini, M., Takahashi, Y., Rotter, M., Rostock, T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.050 · Cited by 345
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177031 · Cited by 345
Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association
Sandau, K. E., Funk, M., Auerbach, A. D., Barsness, G. W., Blum, K., Cvach, M. M., Lampert, R., May, J. L., McDaniel, G. M., Perez, M. V., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000527 · Cited by 370
Detection of Pulmonary Vein and Left Atrial Scar after Catheter Ablation with Three-dimensional Navigator-gated Delayed Enhancement MR Imaging: Initial Experience1
Peters, D. C., Wylie, J. V., Hauser, T. H., Kissinger, K. V., Botnar, R. M., Essebag, V., Josephson, M. E., & Manning, W. J. (2007) · Radiology · doi:10.1148/radiol.2433060417 · Cited by 336
Valsartan for Prevention of Recurrent Atrial Fibrillation
Modena, M. G. (2009) · New England Journal of Medicine · doi:10.1056/nejmx090019 · Cited by 328
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
Brieger, D. B., Amerena, J. V., Attia, J., Bajorek, B. V., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T. L., Haqqani, H. M., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 335
“3% internationally, although they are thought to be lower in Australian practice [344].”
Anatomic Relations Between the Esophagus and Left Atrium and Relevance for Ablation of Atrial Fibrillation
Sánchez‐Quintana, D., Cabrera, J. Á., Climent, V. E., Farré, J., de Mendonça, M. C., & Ho, S. Y. (2005) · Circulation · doi:10.1161/circulationaha.105.551291 · Cited by 320
Complications of Catheter Ablation of Atrial Fibrillation
Gupta, A., Perera, T., Ganesan, A. N., Sullivan, T., Lau, D. H., Roberts‐Thomson, K. C., Brooks, A. G., & Sanders, P. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000768 · Cited by 318
“9%).(6,13) There was also a lower pooled incidence of procedure-related deaths (0.”
BackgroundInfluential
Clinical Outcomes of Catheter Substrate Ablation for High-Risk Patients With Atrial Fibrillation
Nademanee, K., Schwab, M., Kosar, E. M., Karwecki, M., Moran, M. D., Visessook, N., Michael, A. D., & Ngarmukos, T. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.044 · Cited by 318
A novel radiofrequency ablation catheter using contact force sensing: Toccata study
Kück, K., Reddy, V. Y., Schmidt, B., Natale, A., Neužil, P., Saoudi, N. C., Kautzner, J., Herrera‐Siklody, C., Hindricks, G., Jaı̈s, P., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.021 · Cited by 311
“8 Range 21–77 42–73 Sex, n (%) Male 29 (67) 23 (68) Cardiovascular history, n (%) Cardiac disorders 14 (33) 8 (24) Secondary arrhythmia 6 (14) 4 (12) Coronary artery disease 4 (9) 1 (3) Heart failure 1 (2) 2 (6) Valvular disease 2 (5) 1 (3) Other cardiac disorder 2 (5) 3 (9) Vascular disorders 22 (51) 20 (59) Hyperten…”
Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
Conen, D., Tedrow, U. B., Koplan, B. A., Glynn, R. J., Buring, J. E., & Albert, C. M. (2009) · Circulation · doi:10.1161/circulationaha.108.830042 · Cited by 312
Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint
Scherr, D., Khairy, P., Miyazaki, S., Aurillac-Lavignolle, V., Pascale, P., Wilton, S. B., Ramoul, K., Komatsu, Y., Roten, L., Jadidi, A., et al. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001943 · Cited by 303
“sistent with the current worldwide experience with this procedure.(1,22)”
Background
Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome
Belle, Y. V., Janse, P., Rivero‐Ayerza, M., Thornton, A. S., Jessurun, E., Theuns, D., & Jordaens, L. J. L. M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm227 · Cited by 299
Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation
Biase, L. D., Burkhardt, J. D., Mohanty, P. K., Sánchez, J., Horton, R., Gallinghouse, G. J., Lakkireddy, D., Verma, A., Khaykin, Y., Hongo, R. H., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.921320 · Cited by 293
Electrophysiologic and Anatomic Characterization of Sites Resistant to Electrical Isolation During Circumferential Pulmonary Vein Ablation for Atrial Fibrillation: A Prospective Study
Kistler, P. M., Ho, S. Y., Rajappan, K., MORPER, M., Harris, S. J., Abrams, D. J., Sporton, S. C., & SCHILLING, R. J. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00981.x · Cited by 290
Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
Piccini, J. P., Lópes, R. D., Kong, M. H., Hasselblad, V., JACKSON, K. P., & Al‐Khatib, S. M. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.856633 · Cited by 289
Incidence of Silent Cerebral Thromboembolic Lesions After Atrial Fibrillation Ablation May Change According to Technology Used: Comparison of Irrigated Radiofrequency, Multipolar Nonirrigated Catheter and Cryoballoon
Gaïta, F., Leclercq, J. F., Schumacher, B., Scaglione, M., Toso, E., Halimi, F., Schade, A., Froehner, S., Ziegler, V., Sergi, D., et al. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02050.x · Cited by 290
Complications of Catheter Ablation for Atrial Fibrillation: Incidence and Predictors
SPRAGG, D. D., Dalal, D., Cheema, A., SCHERR, D., Chilukuri, K., Cheng, A., Henrikson, C. A., Marine, J. E., Berger, R. D., Dong, J., et al. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01181.x · Cited by 286
Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation
Shah, R. U., Freeman, J. V., Shilane, D. A., Wang, P. J., Go, A. S., & Hlatky, M. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.068 · Cited by 281
Randomized Ablation Strategies for the Treatment of Persistent Atrial Fibrillation
Dixit, S., Marchlinski, F. E., Lin, D., Callans, D. J., Bala, R., Riley, M. P., Garcia, F. C., Hutchinson, M. D., Ratcliffe, S. J., Cooper, J. M., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966226 · Cited by 281
“The following settings were used to identify CFE: (1) for NavX, 5-second segments were acquired with a refractory period of 50 milliseconds (width, 10; sensitivity, 0.5–1.0 mV); (2) for CARTO, 2.5-second segments were acquired with a threshold of 0.05 to 0.5 mV. CFEs were considered present when the mean fractionation…”
MethodInfluential
Bleeding risk assessment and management in atrial fibrillation patients
Fauchier, L., Hylek, E. M., Knight, E., Lane, D. A., Levi, M. M., Marín, F. R., Palareti, G., Jp, C., Rubboli, A., Poli, D., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-10-0690 · Cited by 283
Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern?
DAGRES, N., HINDRICKS, G., KOTTKAMP, H., SOMMER, P., GASPAR, T., BODE, K., ARYA, A., HUSSER, D., RALLIDIS, L. S., KREMASTINOS, D. T., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01493.x · Cited by 279
Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study
Luik, A., Radzewitz, A., Kieser, M., Walter, M., Bramlage, P., Hörmann, P., Schmidt, K., Horn, N., Brinkmeier-Theofanopoulou, M., Kunzmann, K., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016871 · Cited by 275
Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias
Bohnen, M., Stevenson, W. G., Tedrow, U. B., Michaud, G. F., John, R. M., Epstein, L. M., Albert, C. M., & Koplan, B. A. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.017 · Cited by 275
Outcomes and complications of catheter ablation for atrial fibrillation in females
Patel, D., Mohanty, P. K., Biase, L. D., Sánchez, J., Shaheen, M. H., Burkhardt, J. D., Bassouni, M., Cummings, J. E., Wang, Y., Lewis, W. R., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.10.025 · Cited by 272
The Impact of CT Image Integration into an Electroanatomic Mapping System on Clinical Outcomes of Catheter Ablation of Atrial Fibrillation
Kistler, P. M., Rajappan, K., JAHNGIR, M., Earley, M. J., Harris, S. J., Abrams, D. J., Gupta, D., Liew, R., Ellis, S. M., Sporton, S. C., et al. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00594.x · Cited by 272
Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database
Gammie, J. S., Haddad, M., Milford-Beland, S., Welke, K. F., Ferguson, T. B., O’Brien, S. M., Griffith, B. P., & Peterson, E. D. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.10.097 · Cited by 264
Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation–German Atrial Fibrillation Competence Network 1 Trial
Kuck, K.-H., Hoffmann, B. A., Ernst, S., Wegscheider, K., Treszl, A., Metzner, A., Eckardt, L., Lewalter, T., Breithardt, G., & Willems, S. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003337 · Cited by 261
“The Gap-AF–AFNET 1 trial was a prospective, multicenter, 2-arm randomized, adaptive trial to investigate the significance of complete linear PVI on the outcome of patients with drug-refractory paroxysmal AF.”
ResultInfluential
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013):– Digest Version –
JCSJointWorkingGroup (2014) · Circulation · Cited by 261
Post-cardiac injury syndromes. An emerging cause of pericardial diseases
Imazio, M., & Hoit, B. D. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.052 · Cited by 260
Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation
Reddy, V. Y., Gibson, D. N., Kar, S., O’Neill, W. W., Doshi, S. K., Horton, R., Buchbinder, M., Gordon, N. T., & Holmes, D. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.010 · Cited by 258
“31% in a worldwide survey of 20,835 procedures (18) and 1.”
Background
Global Burden of Atrial Fibrillation in Developed and Developing Nations
Chugh, S. S., Roth, G. A., Gillum, R. F., & Mensah, G. A. (2014) · Global Heart · doi:10.1016/j.gheart.2014.01.004 · Cited by 257
“Almost 2 decades ago, therapeutic catheter-based radiofrequency ablation was introduced into the AF treatment armamentarium and is currently finding increasing use but is restricted largely to high-income countries [40].”
Background
Long-Term Quality of Life After Ablation of Atrial Fibrillation
Wokhlu, A., Monahan, K. H., Hodge, D. O., Asirvatham, S. J., Friedman, P. A., Munger, T. M., Bradley, D. J., Bluhm, C. M., Haroldson, J. M., & Packer, D. L. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.040 · Cited by 242
Postoperative Arrhythmias after Cardiac Surgery: Incidence, Risk Factors, and Therapeutic Management
Peretto, G., Durante, A., Limite, L. R., & Cianflone, D. (2014) · Cardiology Research and Practice · doi:10.1155/2014/615987 · Cited by 243
“However, inconsistent data about results of LA ablation following POAF have been published so far [95].”
Background
Atrial fibrillation
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Gelder, I. C. V., Natale, A., Gianni, C., Nattel, S., Potpara, T., Rienstra, M., Tse, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.16 · Cited by 248
Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)
Kück, K., Lebedev, D. S., Mikhaylov, E. N., Romanov, A. B., Gellér, L., Kalējs, O., Neumann, T., Davtyan, K. V., On, Y. K., Popov, S. V., et al. (2020) · EP Europace · doi:10.1093/europace/euaa298 · Cited by 236
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.001 · Cited by 229
Management of atrial fibrillation
Lip, G. Y., & Tse, H.-F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61300-2 · Cited by 229
Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation
Holmes, D. R., Monahan, K. H., & Packer, D. L. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.12.014 · Cited by 226

Authors: Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.-H., Klein, G., Natale, A., Packer, D., Skanes, A., Ambrogi, F., & Biganzoli, E.
Affiliations: The Royal Melbourne Hospital (AU)
ORCID: Cappato, Riccardo
Calkins, Hugh
Chen, Shih-Ann
Kalman, Jonathan
Kim, You-Ho
Klein, George
Natale, Andrea
Packer, Douglas
Skanes, Allan
Ambrogi, Federico
Biganzoli, Elia
Venue: Circulation Arrhythmia and Electrophysiology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-02
Volume: 3
Issue: 1
Pages: 32-38
ISSN: 1941-3084 (ISSN-L)
1941-3149
DOI: 10.1161/circep.109.859116
OpenAlex: W2146673314
Cited by: 2,852
References: 34
Citations by year: 2026: 26 · 2025: 42 · 2024: 51 · 2023: 68 · 2022: 81 · 2021: 110 · 2020: 126 · 2019: 125 · 2018: 141 · 2017: 177 · 2016: 199 · 2015: 184 · 2014: 220 · 2013: 246 · 2012: 218
FWCI: 156.54
Type: journal article
Language: en
Open access: closed
Locations: Circulation Arrhythmia and Electrophysiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: catheter ablation, atrial fibrillation, paroxysmal atrial fibrillation, persistent atrial fibrillation, ablation efficacy, ablation safety, procedural complications, CARTO system
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Anticoagulants, Atrial Fibrillation, Data Collection, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Treatment Outcome, Catheter Ablation, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks